Peripheral Artery Disease Market Size Projected to Reach USD 5.71 Billion By 2027 at a 8.5% CAGR, Says AMR

Allied Market Research published a report, titled, "𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐫𝐭𝐞𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐓𝐲𝐩𝐞 (𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐧𝐠𝐢𝐨𝐩𝐥𝐚𝐬𝐭𝐲 𝐁𝐚𝐥𝐥𝐨𝐨𝐧𝐬, 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐒𝐭𝐞𝐧𝐭𝐬, 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐂𝐚𝐭𝐡𝐞𝐭𝐞𝐫𝐬, 𝐈𝐧𝐟𝐞𝐫𝐢𝐨𝐫 𝐕𝐞𝐧𝐚 𝐂𝐚𝐯𝐚 (𝐈𝐕𝐂) 𝐅𝐢𝐥𝐭𝐞𝐫𝐬, 𝐏𝐥𝐚𝐪𝐮𝐞 𝐌𝐨𝐝𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐢𝐜𝐞𝐬, 𝐇𝐞𝐦𝐨𝐝𝐲𝐧𝐚𝐦𝐢𝐜 𝐅𝐥𝐨𝐰 𝐀𝐥𝐭𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐢𝐜𝐞𝐬, 𝐚𝐧𝐝 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐜𝐜𝐞𝐬𝐬𝐨𝐫𝐢𝐞𝐬): 𝐆𝐥𝐨𝐛𝐚𝐥 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭, 𝟐𝟎𝟐𝟎-𝟐𝟎𝟐𝟕." According to the report, the global Peripheral Artery Disease Market Size Was Valued at USD 3.52 billion in 2019 and it is estimated to surpass around USD 5.71 billion by 2027, with a registered CAGR of 8.5% from 2020 to 2027.

The growth of the peripheral artery disease market is driven by a surge in prevalence of peripheral artery disease. According to the 2023 report by the National Library of Medicine, it was reported that peripheral artery disease affects over 200 million adults worldwide. Furthermore, rise in adoption of the minimally invasive procedures is also expected to contribute significantly in the growth of the market.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/4315

𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐫𝐭𝐞𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: -

• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical
• Cardinal Health, Inc.
• Becton, Dickinson and Company
• Terumo Corporation
• Koninklijke Philips N.V
• AngioDynamics, Inc.
• BIOTRONIK
• B. Braun Melsungen AG

𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐫𝐭𝐞𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: -

Based on type, the peripheral stents segment contributed to the largest market share, holding nearly two-fifths of the total share of the global peripheral artery disease market in 2019, and is expected to maintain its highest contribution during the forecast period. This is attributed to technological innovations leading to development of bio-engineered stents, dual therapy stents, and EPC capture stents. However, the plaque modification devices segment is expected to grow at the largest CAGR of 9.5% from 2020 to 2027. This is due to necessity of these devices while ballooning of arteries fail.

Based on region, North America accounted for the highest share in terms of revenue, contributing to nearly two-fifths of the global peripheral artery disease market in 2019, and will maintain its lead position during the forecast period. This is due to changes in lifestyle habits such as unhealthy dietary habits, smoking, excessive alcohol consumption, and lack of physical activity of people in the region. However, Asia-Pacific is expected to grow at the highest CAGR of 9.4% from 2020 to 2027, owing to expansion of healthcare budgets, rise in disposable income, and surge in demand for technologically advanced devices.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/4315

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.